Sjogren Syndrome With Other Organ Involvement Clinical Trial
Official title:
Tacrolimus for Mild Thrombocytopenia in Sjogren's Syndrome
This 12-week randomized, open-label study evaluates the efficacy and safety of Tacrolimus for Sjogren's syndrome patients with thrombocytopenia.
This study evaluates the efficacy and safety of Tacrolimus for the treatment of thrombocytopenia in Sjogren's syndrome patients. ;